The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The investigation was unable to determine a cause for the reported thrombosis.Thrombosis is listed in the instructions for use as a known possible complication associated with the mitraclip procedures.The reported medication required was a result of case specific circumstance.There is no indication of a product issue with respect to manufacture, design, or labeling.
|
It was reported that a mitraclip procedure was performed to treat a functional mitral regurgitation (mr) with grade of 4.During the procedure, while the device was in the left atrium, a thrombus was noted on the clip delivery system (cds).The device was removed, and a replacement was used to complete the procedure.Additional heparin was given and then a higher than typical maintained.Two clips were implanted with no reported issue, reducing mr to grade 1.There was no clinically significant delay in the procedure and no adverse patient sequelae.
|